中國投資開發(00204.HK)委任張軍澤為非執行董事
格隆匯7月27日丨中國投資開發(00204.HK)公吿,陳順清女士獲委任為公司獨立非執行董事以及提名委員會、薪酬委員會和風險管理委員會委員,並接替莫莉女士為審核委員會主席。張軍澤先生獲委任為公司非執行董事。陳女士已獲委任接替韓正海先生為公司授權代表。
陳女士亦已獲委任接替韓先生為公司根據香港法例第622章公司條例所指的授權代表,作為公司在香港接收將向公司送達的法律程序文件或通知的代表,自2022年7月27日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.